[go: up one dir, main page]

MX2013002381A - Celulas precursoras cd27 1 derivadas de medula osea para reparacion cardiaca. - Google Patents

Celulas precursoras cd27 1 derivadas de medula osea para reparacion cardiaca.

Info

Publication number
MX2013002381A
MX2013002381A MX2013002381A MX2013002381A MX2013002381A MX 2013002381 A MX2013002381 A MX 2013002381A MX 2013002381 A MX2013002381 A MX 2013002381A MX 2013002381 A MX2013002381 A MX 2013002381A MX 2013002381 A MX2013002381 A MX 2013002381A
Authority
MX
Mexico
Prior art keywords
bone marrow
precursor cells
marrow derived
cardiac repair
repair
Prior art date
Application number
MX2013002381A
Other languages
English (en)
Other versions
MX340185B (es
Inventor
Joshua M Hare
Ian K Mcniece
Original Assignee
Univ Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Miami filed Critical Univ Miami
Publication of MX2013002381A publication Critical patent/MX2013002381A/es
Publication of MX340185B publication Critical patent/MX340185B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Los métodos para el aislamiento de poblaciones de células madre CD271+ son importantes en la prevención o tratamiento de la reparación cardiovascular y enfermedades del tejido cardiaco. Los métodos son aplicables a células madre de fuentes diferentes y se pueden utilizar para tratar o prevenir enfermedades o reparar tejidos en otras partes de cuerpo del organismo.
MX2013002381A 2010-08-27 2011-08-29 Células precursoras cd27 1 derivadas de médula ósea para reparación cardíaca. MX340185B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37766110P 2010-08-27 2010-08-27
PCT/US2011/049542 WO2012027740A1 (en) 2010-08-27 2011-08-29 Bone marrow derived cd271 precursor cells for cardiac repair

Publications (2)

Publication Number Publication Date
MX2013002381A true MX2013002381A (es) 2013-04-29
MX340185B MX340185B (es) 2016-06-29

Family

ID=45723836

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013002381A MX340185B (es) 2010-08-27 2011-08-29 Células precursoras cd27 1 derivadas de médula ósea para reparación cardíaca.

Country Status (14)

Country Link
US (3) US20140023621A1 (es)
EP (1) EP2608797B1 (es)
JP (1) JP6061345B2 (es)
KR (1) KR101920891B1 (es)
CN (1) CN103221058B (es)
AU (1) AU2011293144B2 (es)
BR (1) BR112013004700B1 (es)
CA (1) CA2842181C (es)
ES (1) ES2556961T3 (es)
IL (1) IL224917A (es)
MX (1) MX340185B (es)
NZ (1) NZ608734A (es)
SG (1) SG188305A1 (es)
WO (1) WO2012027740A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104508124B (zh) 2011-07-06 2017-11-17 细胞治疗有限公司 中胚层谱系祖细胞
JP6090735B2 (ja) * 2012-03-02 2017-03-08 国立大学法人山口大学 消化器系がん幹細胞を培養するための無血清培地、及びそれを用いた消化器系がん幹細胞の増殖方法
WO2013163539A1 (en) * 2012-04-26 2013-10-31 The Cohen Mcniece Foundation Human fetal heart derived stromal cells for treatment of patients following a myocardial infarction
CN104936603A (zh) 2012-08-01 2015-09-23 联合治疗公司 利用前列环素处理的内皮祖细胞的肺动脉高血压的治疗
IN2015DN00934A (es) 2012-08-01 2015-06-12 United Therapeutics Corp
WO2014110094A1 (en) 2013-01-09 2014-07-17 United Therapeutics Corporation Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
US10456943B2 (en) * 2014-12-03 2019-10-29 Urschel Laboratories, Inc. Machines and methods for cutting products and impellers therefor
AU2015371011B2 (en) * 2014-12-23 2021-07-15 Mesoblast International Sàrl Prevention of progressive heart failure
CA2971512C (en) * 2014-12-23 2025-09-16 Mesoblast International Sarl METHOD FOR TREATING HEART FAILURE
JP6777840B2 (ja) * 2015-12-25 2020-10-28 北海道公立大学法人 札幌医科大学 脳梗塞の治療用医薬
CN106474456A (zh) * 2016-10-18 2017-03-08 广州赛莱拉干细胞科技股份有限公司 一种细胞制剂及其制备方法和应用
IL266175B2 (en) 2016-10-24 2024-01-01 United Therapeutics Corp Enhancement of msc immunomodulatory properties by treprostinil
WO2020069215A1 (en) * 2018-09-27 2020-04-02 Biocardia, Inc. Bone marrow derived neurokinin-1 receptor positive (nk1r+) precursor cells for therapeutic applications
CN110302212A (zh) * 2019-07-17 2019-10-08 陶正博 一种用于治疗急性心肌梗死的细胞制剂及其制备方法
EP4022042A1 (en) * 2019-08-28 2022-07-06 Astellas Institute for Regenerative Medicine Methods of treating vascular diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142457A1 (en) * 1999-12-28 2002-10-03 Akihiro Umezawa Cell having the potentiality of differentiation into cardiomyocytes
NZ533033A (en) * 2001-11-21 2006-01-27 Yeda Res & Dev Process for the manufacture of human mononuclear phagocytic leukocytes
JP2009060840A (ja) * 2007-09-06 2009-03-26 Keio Gijuku ヒト間葉系幹細胞濃縮方法
WO2009140452A2 (en) * 2008-05-15 2009-11-19 University Of Miami Isolation of stem cell precursors and expansion in non-adherent conditions
US20110305673A1 (en) * 2008-11-12 2011-12-15 The University Of Vermont And State Agriculture College Compositions and methods for tissue repair

Also Published As

Publication number Publication date
JP2013542178A (ja) 2013-11-21
IL224917A (en) 2017-02-28
EP2608797B1 (en) 2015-09-23
US20140023621A1 (en) 2014-01-23
CA2842181A1 (en) 2012-03-01
ES2556961T3 (es) 2016-01-21
EP2608797A1 (en) 2013-07-03
US20180214486A1 (en) 2018-08-02
SG188305A1 (en) 2013-04-30
KR101920891B1 (ko) 2018-11-21
CN103221058A (zh) 2013-07-24
CN103221058B (zh) 2015-07-29
WO2012027740A1 (en) 2012-03-01
BR112013004700B1 (pt) 2020-12-08
NZ608734A (en) 2014-09-26
CA2842181C (en) 2021-01-05
AU2011293144A1 (en) 2013-04-18
AU2011293144B2 (en) 2015-04-23
BR112013004700A2 (pt) 2017-07-04
US20230071551A1 (en) 2023-03-09
JP6061345B2 (ja) 2017-01-18
KR20130106381A (ko) 2013-09-27
MX340185B (es) 2016-06-29
EP2608797A4 (en) 2014-01-22

Similar Documents

Publication Publication Date Title
MX340185B (es) Células precursoras cd27 1 derivadas de médula ósea para reparación cardíaca.
MX2010003019A (es) Celulas adherentes de los tejidos adiposo y de placenta y uso de las mismas en la terapia.
WO2011002239A3 (ko) 포유류의 유핵세포에서 유래된 마이크로베시클 및 이의 용도
NZ612455A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
WO2012071526A3 (en) Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
NZ591293A (en) Methods and compositions for treatment of bone defects with osteogenic placental adherent cells (OPACs)
NZ603376A (en) Smooth muscle cell constructs
MX2010005018A (es) Tratamiento de complicaciones de nacimiento prematuro.
MX2009004238A (es) Metodos y composiciones para tratamiento de defectos oseos con poblaciones de celulas de placenta.
WO2011049414A3 (ko) 지방조직 유래 성체 줄기세포 이동을 유도하는 방법
NZ623454A (en) Pharmaceutical composition for the treatment of heart diseases
WO2006127007A3 (en) Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
NZ595331A (en) Ex-vivo treatment of immunological disorders with pkc-theta inhibitors
IL287171A (en) Production of active, patient-specific thymus tissue in vivo from induced pluripotent stem cells
PH12013501773A1 (en) Nutritional compositions for increasing arginine levels and methods of using same
WO2012047951A3 (en) Human lung stem cells and uses thereof
WO2009114703A3 (en) Combination therapy for the treatment of cancer
WO2011151815A3 (en) Implant with body and at least one flute
WO2011035018A3 (en) Suicide ready cells
WO2011118954A3 (ko) 사람 하비갑개 유래 중간엽 기질세포로부터 연골, 골, 신경세포 또는 지방세포를 분화시키는 방법
NZ595440A (en) Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds
WO2014053906A3 (en) The application of stem cells in the orthodontic maxillary expansion
WO2013055889A3 (en) Implantable scaffolds and methods of use
SG11201900986YA (en) Alleviation and treatment of ischemia reperfusion-induced lung injury using pluripotent stem cells
WO2009046346A8 (en) Stem cell therapy for weight loss

Legal Events

Date Code Title Description
FG Grant or registration